5. What to do next Ask your doctor about screening tests Estimate your risk Keep your weight in check Learn your family medical history Connect with relevant groups Talk with a genetic counselor
13. Conclusion DTC genetic industry—like the entire genetic industry— needs a clear and rational regulatory oversight framework that also allows companies to contribute meaningfully to personalized medicine and improved health care .
Notas del editor
We offer a variety of health information.
3 rd point: physician is necessary to the process info. We do not argue with this but we think there are other ways as well. We are providing tools to minimize the chance of both of these outcomes. We give our data in context. As you can see here, when a person gets their data, they are comparing the average person’s risk against their own risk. We also provide extensive information about the condition and we give them steps on what to do next; these steps include encouraging consumers to discuss their results with their physician and to speak with a genetic counselor. Besides this, we have a myriad of tools to help educate consumers about their genetic information. My colleague will discuss our education in a later session. Reveal is also beginning a trial now to study the topic of how people handle the information with and without physicians as intermediaries.
3 rd point: physician is necessary to the process info. We do not argue with this but we think there are other ways as well. We are providing tools to minimize the chance of both of these outcomes. We give our data in context. As you can see here, when a person gets their data, they are comparing the average person’s risk against their own risk. We also provide extensive information about the condition and we give them steps on what to do next; these steps include encouraging consumers to discuss their results with their physician and to speak with a genetic counselor. Besides this, we have a myriad of tools to help educate consumers about their genetic information. My colleague will discuss our education in a later session. Reveal is also beginning a trial now to study the topic of how people handle the information with and without physicians as intermediaries.
We will be listening today, have been thinking about this and will be sharing Ideas with FDA Friday
DTC Industry needs clear and rational regulatory oversight framework to thrive and contribute meaningfully to personalized medicine